Eton Bioscience
Private Company
Total funding raised: $1.5M
Overview
Eton Bioscience is a U.S.-based contract research organization (CRO) and product supplier focused on enabling genetic and genomic research. Its core business model revolves around providing essential, high-quality research services such as Sanger and Oxford Nanopore sequencing, oligonucleotide synthesis, and molecular biology services with an emphasis on affordability, speed, and reliability. The company has expanded from its San Diego roots to establish a national footprint, catering to a broad customer base in academia and industry. While not a therapeutic developer, Eton operates as a critical support infrastructure within the broader biotech ecosystem.
Technology Platform
Integrated suite of molecular biology and protein services, including Sanger sequencing, Oxford Nanopore whole-plasmid sequencing, oligo synthesis, gene synthesis, cloning, and antibody production.
Funding History
1Opportunities
Risk Factors
Competitive Landscape
Eton competes in a fragmented market with large players like Thermo Fisher Scientific and Eurofins Scientific offering extensive service portfolios, and hundreds of smaller regional and niche CROs. Its differentiation is based on competitive pricing, fast turnaround times, a broad menu of essential services, and a dedicated focus on customer support for the research community.